These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23320246)

  • 21. gamma-Secretase as a therapeutic target in Alzheimer's disease.
    Guardia-Laguarta C; Pera M; Lleó A
    Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).
    Lessard CB; Cottrell BA; Maruyama H; Suresh S; Golde TE; Koo EH
    PLoS One; 2015; 10(12):e0144758. PubMed ID: 26678856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
    Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
    J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
    Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
    J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease.
    Basi GS; Hemphill S; Brigham EF; Liao A; Aubele DL; Baker J; Barbour R; Bova M; Chen XH; Dappen MS; Eichenbaum T; Goldbach E; Hawkinson J; Lawler-Herbold R; Hu K; Hui T; Jagodzinski JJ; Keim PS; Kholodenko D; Latimer LH; Lee M; Marugg J; Mattson MN; McCauley S; Miller JL; Motter R; Mutter L; Neitzel ML; Ni H; Nguyen L; Quinn K; Ruslim L; Semko CM; Shapiro P; Smith J; Soriano F; Szoke B; Tanaka K; Tang P; Tucker JA; Ye XM; Yu M; Wu J; Xu YZ; Garofalo AW; Sauer JM; Konradi AW; Ness D; Shopp G; Pleiss MA; Freedman SB; Schenk D
    Alzheimers Res Ther; 2010 Dec; 2(6):36. PubMed ID: 21190552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
    Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
    Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ.
    Fernandez MA; Biette KM; Dolios G; Seth D; Wang R; Wolfe MS
    Biochemistry; 2016 Oct; 55(40):5675-5688. PubMed ID: 27649271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
    Liu L; Lauro BM; Wolfe MS; Selkoe DJ
    J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in gamma-secretase modulation.
    Pissarnitski D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abeta 11-40/42 production without gamma-secretase epsilon-site cleavage.
    Kume H; Kametani F
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1356-60. PubMed ID: 16979587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization.
    So PP; Zeldich E; Seyb KI; Huang MM; Concannon JB; King GD; Chen CD; Cuny GD; Glicksman MA; Abraham CR
    Am J Neurodegener Dis; 2012; 1(1):75-87. PubMed ID: 22822474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms that synergistically regulate η-secretase processing of APP and Aη-α protein levels: relevance to pathogenesis and treatment of Alzheimer's disease.
    Ward J; Wang H; Saunders AJ; Tanzi RE; Zhang C
    Discov Med; 2017 Feb; 23(125):121-128. PubMed ID: 28371615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of membrane lipids on the activity and processivity of purified γ-secretase.
    Holmes O; Paturi S; Ye W; Wolfe MS; Selkoe DJ
    Biochemistry; 2012 May; 51(17):3565-75. PubMed ID: 22489600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.
    Zoltowska KM; Berezovska O
    Mol Neurobiol; 2018 Mar; 55(3):2275-2284. PubMed ID: 28332150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
    Cai Z; Zhao Y; Zhao B
    Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic Aβ generation in familial Alzheimer's disease: novel mechanistic insights and therapeutic implications.
    Trambauer J; Fukumori A; Steiner H
    Curr Opin Neurobiol; 2020 Apr; 61():73-81. PubMed ID: 32105841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.